What Is The Current and Historic Market Size Analysis Of The Congenital Heart Defect Devices Market?
The congenital heart defect devices market has seen considerable growth due to a variety of factors.
• The congenital heart defect devices market has seen strong growth recently. It will expand from $2.91 billion in 2024 to $3.13 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%.
This growth is linked to rising healthcare awareness campaigns, the increasing number of heart defect screening programs, stricter medical device regulations, a higher prevalence of congenital heart defects, and an increased risk of organ failure.
What Is The Forecast For The Congenital Heart Defect Devices Market Size?
The congenital heart defect devices market is expected to maintain its strong growth trajectory in upcoming years.
• The congenital heart defect devices market is expected to grow to $4.13 billion by 2029, with a CAGR of 7.2%.
Growth factors include more clinical trials, a growing geriatric population, rising congenital heart defect prevalence, government funding, and more specialized medical centers. Trends in this period include advancements in technology, digital health, personalized medicine, 3D printing, and wearable devices.
What Are The Essential Drivers Behind The Growth Of The Congenital Heart Defect Devices Market?
The rising number of minimally invasive procedures is expected to boost the congenital heart defect device market. Minimally invasive procedures, which involve small incisions and specialized tools, are growing due to advances in technology and patient preference for less invasive treatments. Devices for congenital heart defects facilitate diagnosis, treatment, and management of heart conditions through smaller incisions or catheter-based approaches. The American Society of Plastic Surgeons reported that in 2022, there was a 7% increase in the number of cosmetic minimally invasive procedures in the United States, indicating a rise in demand for such devices.
How Is The Global Congenital Heart Defect Devices Market Divided Into Key Segments?
The congenital heart defect devices market covered in this report is segmented –
1) By Device Type: Catheters, Pacemakers, Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers, Leadless Pacemakers, Implantable Cardioverter Defibrillators, Biventricular Devices, Implanted Cardiac Loop Recorders, Other Device Types
2) By Defect Type: Atrial Septal Defect, Ventricular Septal Defect, Atrioventricular Septal Defect, Tricuspid Atresia, Truncus Arteriosus, Other Defect Types
3) By End user: Hospitals, Specialty Clinics, Academic And Research Institute, Other End Users
Subsegments:
1) By Catheters: Balloon Catheters, Diagnostic Catheters, Guiding Catheters
2) By Pacemakers: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers, Leadless Pacemakers
3) By Implantable Cardioverter Defibrillators: Single-Chamber Icds, Dual-Chamber Icds, Subcutaneous Icds
4) By Biventricular Devices: Crt-P (Cardiac Resynchronization Therapy Pacemakers), Crt-D (Cardiac Resynchronization Therapy Defibrillators)
5) By Implanted Cardiac Loop Recorders: Traditional Implantable Loop Recorders, Subcutaneous Implantable Loop Recorders
6) By Other Device Types: Transcatheter Heart Valves, Ventricular Assist Devices (VADS)
Pre-Book The Congenital Heart Defect Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Congenital Heart Defect Devices Market?
Companies in the congenital heart defect devices market are forming strategic partnerships to develop innovative devices. These partnerships enhance research and development, expand market access, and accelerate commercialization. For example, in May 2024, SMT (Sahajanand Medical Technologies Pvt Ltd), an India-based manufacturer, partnered with HeartX to improve patient care in the cardiovascular sector. This collaboration enables SMT to offer advanced congenital heart defect devices, such as the JOVE VB Stent, improving treatment outcomes.
Who Are the Key Players In The Congenital Heart Defect Devices Market?
Major companies operating in the congenital heart defect devices market are:
• Pfizer Inc.
• Johnson & Johnson
• AstraZeneca plc.
• Abbott Laboratories
• GlaxoSmithKline plc.
• Medtronic plc.
• Philips Healthcare
• Boston Scientific Corporation
• W. L. Gore & Associates Inc.
• Masimo Corporation
• Lepu Medical Technology (Beijing) Co. Ltd.
• MicroPort Scientific Corporation
• Stereotaxis Inc.
• Berlin Heart GmbH
• Ventracor Limited
• Syncardia Systems LLC
• On-X Life Technologies Inc.
• Occlutech Holding AG
• Sahajanand Medical Technologies Pvt. Ltd.
• Response Biomedical Corporation
• Xeltis AG
• Procyrion Inc.
• Heartstitch Inc.
• Cardia Inc.
• OSYPKA Medical GmbH
What Are The Regional Insights Into The Congenital Heart Defect Devices Market?
North America was the largest region in the congenital heart defect devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congenital heart defect devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
